NCT07893106

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-10-13Est. Completion: 2027-04

Enrollment target: 86 participants

Locations

Contact

Chronic Graft vs. Host Disease

Background: * Chronic graft-versus-host disease (cGVHD) is a multi-organ alloimmune and autoimmune disorder that occurs…

Bethesda, United States

Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7

This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients …

Fairbanks, United StatesEst. completion Jul 17, 2018

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.